Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia A Greinacher, K Selleng, R Palankar, J Wesche, S Handtke, M Wolff, ... Blood, The Journal of the American Society of Hematology 138 (22), 2256-2268, 2021 | 331 | 2021 |
Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis E Stavrou, AH Schmaier Thrombosis research 125 (3), 210-215, 2010 | 234 | 2010 |
Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing A Opneja, S Kapoor, EX Stavrou Thrombosis research 179, 56-63, 2019 | 195 | 2019 |
Immune thrombocytopenia in pregnancy E Stavrou, KR McCrae Hematology/oncology clinics of North America 23 (6), 1299, 2009 | 176 | 2009 |
Plasma contact system activation drives anaphylaxis in severe mast cell–mediated allergic reactions A Sala-Cunill, J Björkqvist, R Senter, M Guilarte, V Cardona, M Labrador, ... Journal of Allergy and Clinical Immunology 135 (4), 1031-1043. e6, 2015 | 171 | 2015 |
The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis KF Nickel, G Ronquist, F Langer, L Labberton, TA Fuchs, C Bokemeyer, ... Blood, The Journal of the American Society of Hematology 126 (11), 1379-1389, 2015 | 160 | 2015 |
Factor XII and uPAR upregulate neutrophil functions to influence wound healing EX Stavrou, C Fang, KL Bane, AT Long, C Naudin, E Kucukal, A Gandhi, ... The Journal of clinical investigation 128 (3), 944-959, 2018 | 148 | 2018 |
Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis GN Adams, GA LaRusch, E Stavrou, Y Zhou, MT Nieman, GH Jacobs, ... Blood, The Journal of the American Society of Hematology 117 (14), 3929-3937, 2011 | 108 | 2011 |
Factor XII: a novel target for safe prevention of thrombosis and inflammation E Kenne, KF Nickel, AT Long, TA Fuchs, EX Stavrou, FR Stahl, T Renné Journal of internal medicine 278 (6), 571-585, 2015 | 107 | 2015 |
Roles of factor XII in innate immunity T Renné, EX Stavrou Frontiers in immunology 10, 2011, 2019 | 104 | 2019 |
Reduced thrombosis in Klkb1−/− mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor EX Stavrou, C Fang, A Merkulova, O Alhalabi, N Grobe, S Antoniak, ... Blood, The Journal of the American Society of Hematology 125 (4), 710-719, 2015 | 94 | 2015 |
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2−/− mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation C Fang, E Stavrou, AA Schmaier, N Grobe, M Morris, A Chen, MT Nieman, ... Blood, The Journal of the American Society of Hematology 121 (15), 3023-3032, 2013 | 92 | 2013 |
Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation H Englert, C Rangaswamy, C Deppermann, JP Sperhake, C Krisp, ... EBioMedicine 67, 2021 | 81 | 2021 |
Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection L Labberton, E Kenne, AT Long, KF Nickel, A Di Gennaro, RA Rigg, ... Nature communications 7 (1), 12616, 2016 | 81 | 2016 |
In vivo activation and functions of the protease factor XII J Björkqvist, KF Nickel, E Stavrou, T Renné Thrombosis and haemostasis 112 (11), 868-875, 2014 | 80 | 2014 |
Prolylcarboxypeptidase promotes angiogenesis and vascular repair GN Adams, EX Stavrou, C Fang, A Merkulova, MA Alaiti, K Nakajima, ... Blood, The Journal of the American Society of Hematology 122 (8), 1522-1531, 2013 | 63 | 2013 |
ClotChip: A microfluidic dielectric sensor for point-of-care assessment of hemostasis D Maji, MA Suster, E Kucukal, UDS Sekhon, AS Gupta, UA Gurkan, ... IEEE transactions on biomedical circuits and systems 11 (6), 1459-1469, 2017 | 57 | 2017 |
Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif MA Cruz, D Bohinc, EA Andraska, J Alvikas, S Raghunathan, NA Masters, ... Nature nanotechnology 17 (9), 1004-1014, 2022 | 55 | 2022 |
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities M Worm, EC Köhler, R Panda, A Long, LM Butler, EX Stavrou, KF Nickel, ... Annals of Translational Medicine 3 (17), 247, 2015 | 55 | 2015 |
Thrombotic microangiopathy in haematopoietic cell transplantation: an update E Stavrou, HM Lazarus Mediterranean journal of hematology and infectious diseases 2 (3), e2010033, 2010 | 50 | 2010 |